India achieves Self-sufficiency for Hepatitis A vaccine, true example of Atma Nirbhar Bharat.
Bangalore, 19th January 2024: Indian Immunologicals Ltd (IIL) a wholly owned subsidiary of National Dairy Development Board (NDDB) and a leading biopharmaceutical company in India marks a historic moment in public health with the launch of India’s first indigenously developed Hepatitis A vaccine “Havisure®”. The vaccine represents a significant step forward in India’s fight against Hepatitis A and is poised to make a substantial contribution to public health.
The new vaccine, Havisure® is the result of extensive research and development efforts by IIL’s dedicated team of scientists and researchers. This indigenously developed vaccine is poised to play a crucial role in preventing Hepatitis A, a highly contagious liver infection that poses a significant public health challenge. Hepatitis A is a viral infection primarily spread through the fecal-oral route, meaning that it is transmitted through the ingestion of contaminated food or water.
This Novel Vaccine launch event was held today at Hyatt Place, Hyderabad. Chief guests were Shri Nagaraj Karpan, MLA and Shri Ajay Mishra, IAS-Chairman Indian Redcross Society, Telangana.
Speaking on the occasion, Dr. K Anand Kumar, Managing Director, Indian Immunologicals Ltd shared “The launch of Havisure® is a testament to our commitment to advancing healthcare solutions for the nation. Currently Hepatitis A vaccines are imported into our country and as a true meaning of Atma Nirbhar Bharat, IIL has tirelessly put in efforts and developed India’s 1st vaccine for Hepatitis A. The vaccine Havisure® has undergone extensive clinical trials in 8 centers and has proven to be safe and efficacious. The vaccine is comparable to the world’s leading vaccine sold by a multinational. With Havisure®, we aim to contribute significantly to the prevention of this infectious disease. IIL launching three vaccines in a single year is itself a big achievement and full credit to my team.”
“Havisure” is set to play a crucial role to protect against the Hepatitis A virus, which primarily affects the liver. The vaccine is effective in preventing the disease and is recommended for children in the routine immunization. It is a two-dose vaccine wherein the first dose is administered at above 12 months of age and the second dose is given at least after 6 months of the first dose. The vaccine is also recommended for individuals who are at risk of exposure or travel to the regions with high hepatitis A prevalence. In addition to this people with occupational risk of infection and suffering from chronic liver diseases also need Hepatitis A vaccination.
Discussing on manufacturing capabilities of IIL, Dr. Priyabrata Pattnaik, Dy. Managing Director-IIL said, “The company has considerably invested in state-of-the-art manufacturing facilities to scale up production and meet the growing demand for Hepatitis A vaccine. As part of the launch, IIL will be collaborating with healthcare professionals, corporate hospitals, and government agencies to promote awareness about Hepatitis A and the importance of both paediatric, adolescent & adult vaccination”.
The bane of old age is when our brain and body don’t keep up with the mind. It has been estimated that 100% ofhumans above the age of 90 have AGE RELATED CEREBRAL ATROPHY (ARCA), moreover 50% above theage of 60 also have the disease. It all sets about with SMALL VESSEL DISEASE (SVD) this could be ischemiaor less blood supply in micro or macro situations when it can be seen in the MAGNETIC RESONANCE IMAGING(MRI).
The patient is usually unaware of the condition and reflects on MRI however as the condition detoriates the patientwill have unsteady gait and balance issues as well as memory and aphasia. Some mood swings are well knownespecially depression. In 2% the patient may go slip into Alzeihmer.
Dr.Agarwal Hospitals and Gene Research Foundation have been doing a study on these patients, where aftergiving them AUTOLOGOUS IMMUNE BOOSTER THERAPY, changes may be seen in the patient themselvesas well as the MRI.
With just one drop of blood from the finger the patient’s vital signs are taken especially the random blood sugar,along with admixing it with MORPHOGENETIC ACTIVATOR OF NUCLEIC ACIDS (MANA). This within onesecond makes the patient’s own fetal healthy DNA and STEM CELLS which is re-injected to the patient.
Depending on the severity of the condition the patient may be needed to take more than one injection subcutaneously and or be given retro bulbar and or intravenous injections as well. Within the first few days the patient realizes the improvement on their emotions and within 3 months the MRI shows signs of reduction of theSVD as well as the cerebral atrophy.
Brain Atrophy (Cerebral Arophy) is a loss of neurons and connections between neurons. Different conditionscause brain atrophy, including cerebral palsy, dementia and infectious diseases. Symptoms and severity of brainatrophy depend on the specific disease and location of damage. Treatment involves managing the underlyingdisorder.
What is brain atrophy?
People with brain atrophy, also called cerebral atrophy, lose brain cells (neurons), and connections betweentheir brain cells and brain volume often decreases. This loss can lead to problems with thinking, memory andperforming everyday tasks. The greater the loss, the more impairment someone has.
There are two types of brain atrophy:
Focal: Damage occurs in one area of your brain.
Generalized: Damage expands to your entire brain.
Is brain atrophy a normal part of aging?
People lose some brain cells as they get older, and brain volume decreases as well, but healthcare providersuse the term “brain atrophy” when a person has more brain changes than expected for age. Here, the damagehappens faster than the typical aging process.
Who is at risk for brain atrophy?
Some factors may increase your chances of developing brain atrophy, such as:
Advanced age.
Family history of genetic disorders, such as Huntington’s disease.
Family history of neurological disorders, such as Alzheimer’s disease.
Head or brain injury.
Heavy drinking (alcohol use disorder).
Smoking.
Does brain atrophy lead to dementia?
There’s a connection between brain atrophy and dementia. Specifically, dementia causes extreme brain atrophy.Dementia is a general term that describes severe thinking problems that interfere with daily life.
The most common type of dementia is Alzheimer’s disease.
Does brain atrophy cause aphasia?
People with aphasia (speaking and language problems) as part of an underlying neurodegenerative disease likeAlzheimer’s disease often have brain atrophy as well. Here, damage occurs in areas responsible for producingand processing language. This disorder ranges in severity. Some people have trouble recalling the correct namefor people, places and things. Others are completely unable to communicate.
Symptoms & Causes
What causes brain atrophy?
Many different disorders, neurodegenerative diseases, infectious diseases and severe injuries can cause brain atrophy, including:
Cerebral palsy.
Encephalitis.
HIV and AIDS.
Huntington’s disease.
Leukodystrophies.
Multiple sclerosis.
Stroke.
Syphilis.
Traumatic brain injury.
Alzheimer’s disease
What are the symptoms of brain atrophy?
Symptoms of brain atrophy vary depending on which specific part of your brain is damaged. Symptoms also range from mild to severe.
In general, brain atrophy happens with various conditions, and symptoms can vary to include:
Aphasia
Difficultypeaking.
Difficulty writing.
Inability to understand the meaning of words.
Dementia
Hallucinations.
Loss of language.
Memory problems
Mood and personality changes.
Poor judgment.
Seizures
Bitter or metallic taste.
Convulsions.
Loss of consciousness.
Spasms.
Teeth clenching.
Diagnosis & Tests
How is brain atrophy diagnosed?
To diagnose brain atrophy and any underlying condition, your healthcare provider will usually ask about your: Symptoms. When did they first start? How often do they occur? Have they gotten worse over time?
Medical history.
Family history of health conditions.
Your healthcare provider will also use different tests to evaluate your brain function. Tests might look at:
Coordination.
Eye movement.
Language.
Memory.
Problem-solving abilities.
Does brain atrophy show on MRI?
Yes, brain atrophy can show up on magnetic resonance imaging (MRI), a test that creates pictures of youra
brain.
A computed tomography (CT) scan can also detect brain atrophy. But an MRI is more sensitive in revealing damage that occurs in some specific regions area of your brain (focal damage).
Management & Treatment
What is the treatment for brain atrophy?
There’s no single treatment for brain atrophy, as it can be a sign of one or more diseases. Rather, healthcare providers tailor treatment to help you manage the symptoms of the underlying condition. Your treatment plan may often include a combination of:
Medication.a
Physical and occupational therapy.
Counseling.
Speech therapy.
Surgery, in some cases.
If you have a stroke, you’ll receive emergency care, such as clot-dissolving medication, as well as stroke rehabilitation.
Prevention
How can I prevent brain atrophy?
Some degree of brain volume change is expected with normal aging. But adopting healthy habits may reducesome risk factors that lead to brain shrinkage and help you improve your day-to-day life:
Eat a nutrient-rich, low-cholesterol diet, such as the Mediterranean diet.
Aim for daily aerobic exercise.
Get enough sleep.
Find healthy ways to manage stress, which has been linked to high blood pressure, heart disease and stroke.
Take medication lower high blood pressure, high cholesterol and control diabetes.
Quit smoking by joining a support group or trying one-on-one counseling.
Reduce alcohol use.
Talk to your healthcare provider about managing risk factors if you’re at high risk.
Outlook / Prognosis
What is the outlook for brain atrophy?
Brain atrophy tends to be permanent. You can’t reverse the damage once it’s happened. But by working with your healthcare providers, you can aim to manage the underlying condition and potentially compensate for some of the symptoms, so you can live a fuller life.
Bengaluru, December 6, 2023 – Samarthanam Trust for the Disabled, a pioneer in creating education and livelihood opportunities for persons with disabilities, proudly announces the17th Bengaluru Walkathon, scheduled for December 9, 2023, at Kittur Rani Chennamma Stadium, Jayanagar at 9.30 am. This annual event, dedicated to promoting inclusivity, this year focuses on the theme “Health for All.”
In a significant development, ZS Associates, a global management consulting and professional services firm head quartered in Evanston, Illinois, has stepped forward as the title sponsor. Z5,with over 12,000 employees across 35 offices worldwide, specializes in consulting, software,and technology, catering to clients in healthcare, private equity, and technology
The Bengaluru Walkathon has been a highlight on the city’s calendar, drawing massive public support each year. Aligned with the International Day of Persons with Disabilities, the event aims to promote the rights and well-being of individuals with disabilities, fostering awareness across all spheres of society.
With the theme “Health for All,” the 17th Walkathon at Samarthanam strives to be a catalyst for change, aiming to empower individuals with disabilities as agents of positive transformation. The event plays a vital role in advancing health equity, ensuring access to crucial health information and services for every disabled person. The Walkathon is a platform for mass awareness on health, focusing on good health and hygiene. Aligned with Sustainable Development Goal 3, the event emphasizes healthy lives and well-being for all. Additionally, the Walkathon benefits marginalized communities, providing nutrition kits to government school students. Inclusivity is paramount, with participants of all ages and genders, promoting a healthier lifestyle and habits. The event also supports healthcare infrastructure by supplying medical consumables to Primary Health Centres and district hospitals, ensuring holistic healthcare for vulnerable individuals. Encouraging active community participation, the Walkathon aims to achieve the overarching goal of “HEALTH FOR ALL”
“I am eagerly anticipating this time of the year as we unveil the theme for this year’s Walkathon – ‘Health for All.’ In a time where prioritizing health is paramount, we are dedicated to fostering equal access for everyone. I extend a warm invitation to each of you tobe a part of this movement towards universal health. It’s heartening to witness thecollaboration of numerous companies in this noble cause. My heartfelt thanks to the title sponsors for their valuable contribution and unwavering support in our collective journey to champion health equity and inclusivity.” Said Dr Mahantesh G Kivadasannavar, Founder Managing Trustee of Samarthanam.
Samarthanam extends heartfelt gratitude to all sponsors, including ZS Associates, Adobe, Paypal, Microsoft, Intertrust Group, Kluber Lubrication, MiQ, Tredence, Q2, GKN Aerospace, and ANZ for their support in promoting Health for All.
The Bengaluru Walkathon invites the community to participate actively and contribute to the cause. For more information and updates on the walkathon, please contact 9480809591 and 9480809589
ಆಸಿಡ್ ದಾಳಿಗೆ ತುತ್ತಾದವರ ಆರೈಕೆಗಾಗಿ ಎಮೋಷನಲ್ ಫಸ್ಟ್ ಏಯ್ಡ್ ಅಕಾಡೆಮಿಯಿಂದ ತರಬೇತಿ ; ಘಟಿಕೋತ್ಸವದಲ್ಲಿ ಇಂದು ಪ್ರಮಾಣ ಪತ್ರ ಪ್ರದಾನ
ಬೆಂಗಳೂರು, ನ, 25; ಆ್ಯಸಿಡ್ ದಾಳಿಗೆ ತುತ್ತಾದವರನ್ನು ಮಾನಸಿಕವಾಗಿ ಬಲಪಡಿಸುವ ಮಹತ್ವದ ಗುರಿ ಹೊಂದಿರುವ ಹಾಗೂ ಮಾನಸಿಕ ಯೋಗ ಕ್ಷೇಮ ಸೇವೆ ನೀಡಲು ತರಬೇತಿ ಪಡೆದವರಿಗೆ ಎಮೋಷನಲ್ ಫಸ್ಟ್ ಏಡ್ ಅಕಾಡೆಮಿಯ ಘಟಿಕೋತ್ಸವದಲ್ಲಿ ಶನಿವಾರ ಪ್ರಮಾಣ ಪತ್ರ ಪ್ರದಾನ ಮಾಡಲಾಗುತ್ತದೆ ಎಂದು ಸಂಸ್ಥೆಯ ಸಂಸ್ಥಾಪಕರಾದ ಪ್ರೊ. ಸುನಿತಾ ಕೆ. ಮಣಿ ತಿಳಿಸಿದ್ದಾರೆ.
ಸುದ್ದಿಗೋಷ್ಠಿಯಲ್ಲಿ ಮಾತನಾಡಿದ ಅವರು, ನಗರದ ರಾಡಿಸನ್ ಬ್ಲ್ಯೂ ಹೋಟೆಲ್ ನಲ್ಲಿ ಪ್ರತಿಷ್ಠಾನದಲ್ಲಿ ತರಬೇತಿಪಡೆದ ಅಭ್ಯರ್ಥಿಗಳೊಂದಿಗೆ ಸಂವಾದ ಏರ್ಪಡಿಸಲಾಗಿದೆ. ಆರೋಗ್ಯ ಕ್ಷೇತ್ರದಲ್ಲಿ ಇದು ಅತ್ಯಂತ ಮಹತ್ವದ ವಲಯವಾಗಿದೆ. ಪ್ರತಿವರ್ಷ ದೇಶದಲ್ಲಿ 800 ಮಂದಿ ಆಸಿಡ್ ದಾಳಿಗೆ ಒಳಗಾಗುತ್ತಿದ್ದು, ಇಂತಹವರ ಆರೈಕೆಗಾಗಿ ಈ ಪ್ರಮಾಣಪತ್ರ ಅತ್ಯಂತ ಮಹತ್ವದ್ದಾಗಿದೆ ಎಂದರು.
ಎಮೋಷನಲ್ ಫಸ್ಟ್ ಏಡ್ ಚಿಕಿತ್ಸಾ ಪೂರೈಕೆದಾರರು, ತರಬೇತಿ ಪಡೆದವರು. ಆ್ಯಸಿಡ್ ದಾಳಿಯಿಂದ ಸಂತಸ್ತರಾದವರು, ಬದುಕುಳಿದವರ ಪುನಶ್ವೇತನಕ್ಕಾಗಿಯೇ ಮೀಸಲಾಗಿರುವ ಛಾನ್ಸ್ ಪ್ರತಿಷ್ಠಾನದೊಂದಿಗೆ ಸಹಯೋಗಲ್ಲಿ ಕಾರ್ಯನಿರ್ವಹಿಸಲಿದ್ದಾರೆ. ತರಬೇತಿ ಪಡೆದವರನ್ನು ಮಾನಸಿಕವಾಗಿ ಸಜ್ಜುಗೊಳಿಸಿ ಶಸ್ತ್ರಸಜ್ಜಿತ ಸೈನಿಕರಂತೆ ಕಾರ್ಯನಿರ್ವಹಿಸಲಿದ್ದಾರೆ. ಆ್ಯಸಿಡ್ ದಾಳಿಗೆ ತುತ್ತಾಗಿ ನೊಂದು, ಬಾಳ ಕತ್ತಲೆಯಲ್ಲಿರುವವರಿಗೆ ಆಶಾಕಿರಣವಾಗಿ ಕಾರ್ಯನಿರ್ವಹಿಸಲಿದ್ದಾರೆ ಎಂದು ಹೇಳಿದರು.
Bangalore, Nov. 25; The certificates will be issued at the convocation ceremony of Emotional First Aid Academy for those involved in mentally strengthening acid attack victims and thos e trained in extending mental wellness services, said Prof. Sunita K Mani, founder of the institute.
Addressing a press, she said that an interaction which was organised for the trainers at the Radison Blue hotel on Palace. This is an important area in the health sector. Nationwide, on an average about 800 people are subjected to acid attacks.
Trainers would be mentally strengthened and they work tirelessly like soldiers. The Academy is like a silver lining in the lives of acid attack victims, she said. for those involved in mentally strengthening acid attack victims and those trained in extending mental wellness services, said Prof. Sunita K Mani, founder of the institute.
City Today News 
You must be logged in to post a comment.